With the help of the ESTIMATE algorithm, FXYD2 was revealed to conversely correlate with immune and stromal scores and positively related to tumor purity which was determined by the percentage of infiltrating immune or stromal cells. The gene discussed is FXYD2; the disease is neoplasm.